Article Sidebar
Published:
Sep 25, 2023Keywords:
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
On acceptance, the copyright of the paper will be vested in the journal and publisher. BOMJ subscribes to the Creative Commons Attribution (CC BY) license to the work we publish to make articles legally available for reuse, without permission or fees.
Therefore, articles published in BOMJ can be copied, distributed, or reused as long as the author and original source are properly cited.
Main Article Content
Bone marrow aspiration (BMA) in Zaria: A three-year retrospective review.
Abstract
Background: BMA is a clinical procedure that exploits microscopy and lends itself to specialized biochemical and molecular assays for diagnosis, staging, prognostication and determining choice of therapy. Eligibility for BMA is determined following review of a patient's history, physical examination findings, Complete Blood Count and other relevant investigations. Bone marrow aspirates may be obtained from different sites of the body such as iliac crest, sternum etc. This study was to determine some patient characteristics, sites, indications and outcomes of all BMAs done between January 2002 and December 2004. It is hoped that this study will help haematologists and other physicians to understand the utility of BMA and some of its limitations.
Material And Methods: It was a three-year retrospective, analytic review of all BMAs done in the Department of Haematology, Ahmadu Bello University Teaching Hospital Zaria. Records from 1st January 2002 to 31st of December 2004 were retrieved, collated and analyzed using SPSS version 16.
Results: A total of One hundred and thirty five (135) BMAs were done in the period under review. There was a male preponderance 77 (57.00%) with females constituting 58 (43.00%). The mean age was 31.78±20.76 years with a mode of 45 years. The minimum and maximum ages were 1 and 78 years respectively. The commonest site for BMA was the RPSIS 97(71.9%). Anaemia was the commonest indication for BMA 56(41.5%) followed by Splenomegaly 15(11.1%) and Lymphadenopathy 14(10.4%).The commonest diagnosis was combined deficiency anaemia 21(15.6%) followed by Megaloblastic anaemia 19(14.1%). Whereas 9(6.7%) were inconclusive, 14(10.4%) were normal. The complication rate was 0% and lymphadenopathy was the commonest indication that turned up with a normal BMA 5/14 (35.7%).
Conclusion: BMA is important in the evaluation of several conditions. However, there is a need to ensure proper consultation to ensure only patients that require BMA do so due to its invasive nature.
